Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present a protocol to measure KDM1A target engagement in a human or animal cell, tissue or blood samples treated with KDM1A inhibitors. The protocol employs chemoprobe tagging of the free KDM1A enzyme and direct quantification of the target occupation using chemoprobe-based immunoassays and can be used in preclinical and clinical studies.

Abstract

The assessment of the target engagement, defined as the interaction of a drug with the protein it was designed for, is a basic requirement for the interpretation of the biological activity of any compound in drug development or in basic research projects. In epigenetics, target engagement is most often assessed by the analysis of proxy markers instead of measuring the union of the compound to the target. Downstream biological readouts that have been analyzed include the histone mark modulation or gene expression changes. KDM1A is a lysine demethylase that removes methyl groups from mono- and dimethylated H3K4, a modification associated with the silencing of gene expression. Modulation of the proxy markers is dependent on the cell type and function of the genetic make-up of the cells investigated, which can make interpretation and cross-case comparison quite difficult. To circumvent these problems, a versatile protocol is presented to assess the dose effects and dynamics of the direct KDM1A target engagement. The assay described makes use of a KDM1A chemoprobe to capture and quantify uninhibited enzyme, can be broadly applied to cells or tissue samples without the need for genetic modification, has an excellent window of detection, and can be used both for basic research and analysis of clinical samples.

Introduction

Lysine specific demethylase 1 (KDM1A)1 is a demethylase involved in the control of gene transcription. This protein has emerged as a candidate pharmacological target2 in oncology; including Acute Myeloid Leukemia3 (AML), Myelodysplasia Syndrome (MDS)4, Myelofibrosis (MF)5,6, Small Cell Lung Cancer (SCLC)7; in Sickle Cell Disease (SCD)8,9, and in central nervous system diseases including Alzheimer's Disease (AD), Multiple Sclerosis....

Protocol

Blood samples were obtained from the Instituto de Investigación Biomédica Sant Pau Biobank according to Spanish legislation (Real Decreto de Biobancos 1716/2011) and approval of the local ethics committees. Studies with animal tissues were performed in accordance with the institutional guidelines for the care and use of laboratory animals (European Communities Council Directive 86/609/EEC) established by the Ethical Committee for Animal Experimentation at the PRAAL-PCB.

1. Pre.......

Representative Results

The Linearity of Total and Free KDM1A determination.

A Standard Series was prepared as described in step 5.3.2., using 0 to 2500 pg of full-length human recombinant KDM1A enzyme. The RLU values of Total and Free rKDM1A were assessed to verify the linearity (Figure 2A and 2B). Data are represented as mean from 3 experiments with 3 technical replicates (n) ± SD. .......

Discussion

The protocol presented here was developed to directly measure KDM1A target engagement using a novel KDM1A chemoprobe capture based ELISA. The method has been validated on cultured human cell lines and ex vivo samples from human, rat and mouse and baboon (including PBMCs, lung, brain, skin, tumors), but can be readily applied to other species in which the KDM1A antibody target epitopes and catalytic center are conserved. As OG-881 is an activity based chemoprobe, the sample quality is important and proper manipulation and.......

Acknowledgements

This study was financed by Oryzon Genomics. S.A., Hoffman-La Roche, and partially supported by the CIIP-20152001 and RETOS collaboration program RTC-2015-3332-1.

....

Materials

NameCompanyCatalog NumberComments
0,05% Trypsin-EDTA (1X)Thermo Scientific#25300-062
10 X Protease Inhibitor TabletsRoche#11836153001
96 deep well storage blockVWR#734-1679
96 well ELISA platesNunc#436110
Adhesive black FilmPerkin Elmer#6050173
Adhesive transparent FilmVWR#60941-062
Biotinylated KDM1A probe OG-881Oryzon Genomics S.A.NA
Bovine Serum AlbuminSigma# 3117057001
Bovine Serum Albumin StandardThermo Scientific#23208)
Bradford Protein AssayBioRad#500-0001
Cell lysis buffer 10XCell Signaling#9803
Centrifuge for 96- well platesHettichRotina 420R
FlaskThermo Scientific#156499
Full length, enzymatically active human Recombinant LSD1 / KDM1AActive Motif#31426
Graphpad Prism 5 ProjectGraphPad SoftwareNA
Luminol-Enhacer and Peroxide Solution (Chemiluminescent Substrate)Thermo Scientific#37074
Micro CentrifugeEppendorf5415 R
Microplate reader Infinite 200-TecanTecanInfinite 200
Mouse monoclonal capture antibody Anti-KDM1A (N-terminal epitope)Abcam#ab53269
Needle G18 gauge bluntBD#303129
ORY-1001 (iadademstat)Oryzon Genomics S.A.NA
PBMC separation tubes 10 mlGreiner bio-one#163288
PBMC separation tubes 50 mlGreiner bio-one#227288
PBS 1xSigma#D8537
Plate shakerHeidolph InstrumentsRotamax 120
Polysorbate 20Sigma#P7949
Rabbit monoclonal detection antibody Anti-KDM1A (C-terminal epitope)Cell Signaling#672184BF-100
Secondary antibody Peroxidase-conjugated Donkey Anti-rabbit IgGThermo Scientific#31458
Spectrophotometer cuvette 1.5Deltalab#302100
Spectrophotometer for cuvetteGE HealthcareGeneQuant 1300
StreptavidinPromega#Z704A
SyringeBD#303172
Type 1 ultrapure waterMilliporeMilli-Q Advantage A10
Ultrasonic cleanerVWRUSC200T

References

  1. Shi, Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 119 (7), 941-953 (2004).
  2. Maiques-Diaz, A., Somervaille, T. C. LSD1: biologic roles and therapeutic targeting. ....

Explore More Articles

Target EngagementKDM1AChemoprobe based ImmunoassayIadademstatORY 1001PharmacodynamicsDrug DevelopmentCell LysisTissue HomogenizationProtease Inhibitor

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved